NCT06488378
- Conditions
- BRCA1 Mutation, BRCA2 Mutation, Breast Cancer, +8 more
- Locations
-
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
- Mayo Clinic Rochester, Minnesota, United States
Clinical trial condition
BRCA1 Mutation
Explore clinical trials studying BRCA1 Mutation. Study availability and eligibility vary by location and protocol.
40 public trials
12 recruiting studies
BRCA1 Mutation trial results
- Conditions
- APC Gene Mutation, ATM Gene Mutation, BARD1 Gene Mutation, +19 more
- Locations
-
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
- Memorial Sloan Kettering Bergen (Limited Protocol Activity) Montvale, New Jersey, United States
- Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities) Commack, New York, United States
NCT06972719
- Conditions
- BRCA1 Mutation, BRCA2 Mutation
- Locations
-
- UNC Chapel Hill Health System Chapel Hill, North Carolina, United States
- Duke University Health System Durham, North Carolina, United States
NCT05694715
- Conditions
- ATM Gene Mutation, BRCA1 Mutation, BRCA2 Mutation, +7 more
- Locations
-
- University of California, San Francisco San Francisco, California, United States
Recruiting
Olaparib and ASTX727 in BRCA1/2- and Homologous Recombination Deficient (HRD)-Mutated Tumors
NCT06177171
- Conditions
- ATM Gene Mutation, BRCA Mutation, BRCA1 Mutation, +3 more
- Locations
-
- University of California, San Francisco San Francisco, California, United States
NCT06395519
- Conditions
- Adnexal Diseases, Advanced or Metastatic Solid Tumors, BRCA Mutation, +52 more
- Locations
-
- Mayo Clinic Phoenix, Arizona, United States
- Yale University, Yale Cancer Center New Haven, Connecticut, United States
- Mayo Clinic Jacksonville, Florida, United States
- University of Chicago Medical Center Chicago, Illinois, United States
Recruiting
SHARON: A Clinical Trial for Metastatic Cancer Using Chemotherapy and Patients' Own Stem Cells
NCT04150042
- Conditions
- Adenocarcinoma of the Breast, BRCA1 Mutation, BRCA2 Mutation, +35 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
- Memorial Sloan Kettering Cancer Center New York, United States
NCT06201234
- Conditions
- Advanced or Metastatic Breast Cancer, BRCA1 Mutation, BRCA2 Mutation, +11 more
- Locations
-
- Vinzenz Von Paul Kliniken gGmbH - Marienhospital Stuttgart, Baden-Wurttemberg, Germany
- University Hospital Tübingen Tübingen, Baden-Wurttemberg, Germany
- Rems-Murr-Klinik-Winnenden Winnenden, Baden-Wurttemberg, Germany
- GRN Klinik Weinheim Weinheim, Baden-Württembergs, Germany
NCT03702309
- Conditions
- Adnexal Diseases, BRCA1 Mutation, BRCA2 Mutation, +85 more
- Locations
-
- Princess Margaret Cancer Centre Toronto, Ontario, Canada
Recruiting
Novel Neoadjuvant and Adjuvant Strategy for Germline BRCA 1/2 Mutated Triple Negative Breast Cancer
NCT05485766
- Conditions
- BRCA Mutation, BRCA-Associated Breast Carcinoma, BRCA1 Mutation, +11 more
- Locations
-
- Gifu University Hospital Gifu, Japan
- Okayama University Hospital Okayama, Japan
- St. Luke's International Hospital Tokyo, Japan